Reports second quarter revenues of $0.1 billion, GAAP net loss of $(0.8) billion and GAAP EPS of $(2.13) Updates 2025 ...

CAMBRIDGE, MA / ACCESS Newswire / August 1, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the UK Court of Appeal ...

Moderna, Inc.'s Q2 2025 earnings highlight a steep revenue decline post-pandemic, with just $0.1bn in revenue and a $(0.8bn) ...

Genetic testing company Myriad Genetics (NASDAQ:MYGN) will be announcing earnings results this Tuesday after market hours.

Bird flu, for the moment, appears to be under control. But experts have a warning for federal and state health officials.

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

The company reported a net loss of $825 million for the quarter. Additionally, Moderna announced a $300 million reduction at the high end of their 2025 projected revenue range due to a timing shift of ...

A strategy of selecting stocks based on rapid revenue growth has outperformed the broad market over the decades.

If you want a Covid-19 shot this fall, will your employer’s health insurance plan pay for it? There’s no clear answer. But ...

Despite gold’s rebound, silver drops on soft China data and trade fears. Explore the full silver analysis and what it means ...

This article explains how aluminum adjuvants work in vaccines, their proven safety record, and addresses common myths and ...

An outbreak of the highly infectious livestock disease would devastate exports and wipe $80 billion from the economy.